FIELD: medicine, therapy. SUBSTANCE: method involves the use of the preparation "Diquertin" that is sum of bioflavanoids, %: dihydroquercitin, 90-92; dihydrokaempferol and naringenin, 8-10. Daily dose of preparation is 0.08-0.24 g. At acute period of disease preparation is used at dose 0.04-0.06 g, 4 times per 24 h, at recovery period - 0.02 g, 4 times per 24 h. Treatment course is 3-4 weeks and it can be repeated. Preparation shows positive effect on liver functional state, improves respiration and heart working. Preparation can be used in pulmonology and cardiology. EFFECT: enhanced effectiveness of method. 5 cl, 10 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR COMPLEX SICKNESS THERAPY AND A METHOD OF ITS PREPARING | 1996 |
|
RU2088256C1 |
| METHOD FOR TREATING OSTEOARTHROSIS CASES AGGRAVATED WITH REACTIVE SYNOVITIS | 2005 |
|
RU2314820C2 |
| VITALARIX CARDIO BIOLOGICALLY ACTIVE SUPPLEMENT | 2007 |
|
RU2357746C2 |
| IMMUNOMODULATORY DRUG IN SECONDARY IMMUNODEFICIENCY STATES | 2008 |
|
RU2375072C1 |
| AGENT FOR TREATMENT OF EYE DISEASE | 2006 |
|
RU2315612C1 |
| AGENT POSSESSING LYMPHOKINETIC ACTIVITY | 2014 |
|
RU2560518C1 |
| AGENT ELICITING ANTIAGGREGATIVE AND HEMORHEOLOGICAL ACTIVITY | 2001 |
|
RU2180848C1 |
| USE OF A PHOSPHOLIPID EMULSION CONTAINING AN EFFECTIVE AMOUNT OF DIHYDROQUERCETIN, LECITHIN AND GLYCINE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY SYSTEM | 2021 |
|
RU2757360C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIARRHYTHMIC ACTIVITY OF VARIOUS ETIOLOGIES | 2021 |
|
RU2783944C1 |
| METHOD OF PREVENTION AND TREATMENT OF CHRONIC VENOUS INSUFFICIENCY USING VENOLAYT BIOLOGICALLY ACTIVE ADDITIVE | 2023 |
|
RU2812617C1 |
